PLoS ONE (Jan 2021)

Correction: Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-βRI inhibitor galunisertib.

  • Gianluigi Giannelli,
  • Armando Santoro,
  • Robin K Kelley,
  • Ed Gane,
  • Valerie Paradis,
  • Ann Cleverly,
  • Claire Smith,
  • Shawn T Estrem,
  • Michael Man,
  • Shuaicheng Wang,
  • Michael M Lahn,
  • Eric Raymond,
  • Karim A Benhadji,
  • Sandrine Faivre

DOI
https://doi.org/10.1371/journal.pone.0253671
Journal volume & issue
Vol. 16, no. 6
p. e0253671

Abstract

Read online

[This corrects the article DOI: 10.1371/journal.pone.0222259.].